KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,135 | +57.8% | 2,714 | +47.5% | 0.00% | 0.0% |
| Q2 2023 | $16,560 | +206900.0% | 1,840 | +77.9% | 0.00% | – |
| Q1 2023 | $8 | -46.7% | 1,034 | -54.9% | 0.00% | -100.0% |
| Q4 2022 | $15 | -99.9% | 2,292 | +17.3% | 0.00% | – |
| Q3 2022 | $29,000 | +38.1% | 1,954 | -7.8% | 0.00% | – |
| Q2 2022 | $21,000 | -34.4% | 2,119 | -3.2% | 0.00% | – |
| Q1 2022 | $32,000 | +255.6% | 2,188 | +218.5% | 0.00% | – |
| Q4 2021 | $9,000 | -40.0% | 687 | -20.6% | 0.00% | – |
| Q3 2021 | $15,000 | -90.5% | 865 | -86.9% | 0.00% | -100.0% |
| Q2 2021 | $158,000 | +66.3% | 6,601 | +79.2% | 0.00% | +100.0% |
| Q1 2021 | $95,000 | +35.7% | 3,684 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $70,000 | -62.8% | 3,674 | -75.5% | 0.00% | 0.0% |
| Q3 2020 | $188,000 | +13.9% | 14,971 | +9.6% | 0.00% | -71.4% |
| Q2 2020 | $165,000 | +266.7% | 13,659 | +252.3% | 0.01% | +133.3% |
| Q3 2019 | $45,000 | +1025.0% | 3,877 | +1919.3% | 0.00% | – |
| Q2 2019 | $4,000 | +300.0% | 192 | +464.7% | 0.00% | – |
| Q1 2019 | $1,000 | -75.0% | 34 | -79.0% | 0.00% | – |
| Q4 2018 | $4,000 | -89.7% | 162 | -90.7% | 0.00% | -100.0% |
| Q3 2018 | $39,000 | +1200.0% | 1,742 | +431.1% | 0.00% | – |
| Q2 2018 | $3,000 | -75.0% | 328 | -74.4% | 0.00% | -100.0% |
| Q1 2018 | $12,000 | +50.0% | 1,281 | +52.5% | 0.00% | 0.0% |
| Q4 2017 | $8,000 | +14.3% | 840 | -7.2% | 0.00% | 0.0% |
| Q2 2017 | $7,000 | +16.7% | 905 | +28.4% | 0.00% | 0.0% |
| Q1 2017 | $6,000 | +200.0% | 705 | +168.1% | 0.00% | – |
| Q4 2016 | $2,000 | – | 263 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,810,246 | $17,432,669 | 7.30% |
| TCG Crossover Management, LLC | 3,395,495 | $32,698,617 | 4.82% |
| TANG CAPITAL MANAGEMENT LLC | 3,440,345 | $33,130,522 | 4.68% |
| VR Adviser, LLC | 2,916,667 | $28,087,503 | 2.96% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $31,190,212 | 2.07% |
| Nan Fung Group Holdings Ltd | 234,573 | $2,258,938 | 1.83% |
| DAFNA Capital Management LLC | 605,532 | $5,831,273 | 1.81% |
| Opaleye Management Inc. | 500,000 | $4,815,000 | 1.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 530,400 | $5,107,752 | 1.55% |
| MPM BioImpact LLC | 577,958 | $5,565,736 | 1.49% |